Clinical Trials

New Search
Title   Phase 2 Study: Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Children and Adolescents With Prader-Willi Syndrome
Disease/Condition   Child Development,Genetic Disorders,Pediatrics,Psychiatry - Non Cancer,Nervous System Diseases

Click here for more information

Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Eric Hollander, MD
Contact Name   Danya Schlussel
Contact Email
Protocol Number   2017-8076
Inclusion/Notes   This information was obtained from
Status   Active/Enrolling
Adult Clinical Trial   No
Pediatric Clinical Trial   Yes
Sub-Specialty   Psychiatry - Brain and Nervous System
Adult, Pediatric, Both   Pediatric